Welcome to Dwaey, specifically on Desvenlafaxine page.
This medicine contains important and useful components, as it consists of
Desvenlafaxine is available in the market in concentration.
Desvenlafaxine
Before initiating Desvenlafaxine, it is essential that patients consult their healthcare provider to assess its suitability for their individual health needs. There are several important precautions to consider:
- Mental health considerations: Desvenlafaxine has been associated with an increased risk of suicidal thoughts and behavior, especially in children, adolescents, and young adults. Close monitoring is necessary, particularly during the initial treatment phase or during dose adjustments.
- Serotonin syndrome: This drug may increase serotonin levels, and combined use with other serotonergic drugs (such as SSRIs, SNRIs, triptans, or certain herbal supplements like St. John’s Wort) can lead to serotonin syndrome, a potentially life-threatening condition. Symptoms include agitation, hallucinations, fever, rapid heart rate, fluctuating blood pressure, and muscle spasms.
- Blood pressure: Desvenlafaxine may increase blood pressure, particularly at higher doses. Blood pressure should be monitored regularly, especially in patients with a history of hypertension. If sustained increases in blood pressure are noted, dose reduction or discontinuation may be necessary.
- Liver and renal function: Desvenlafaxine should be used with caution in patients with liver or renal impairments. Dosage adjustments may be required for individuals with significant liver or kidney dysfunction.
- Withdrawal symptoms: Abrupt discontinuation of Desvenlafaxine can lead to withdrawal symptoms such as dizziness, nausea, fatigue, and irritability. A gradual tapering of the dose is recommended when discontinuing therapy.
Desvenlafaxine is primarily indicated for the treatment of major depressive disorder (MDD) in adults. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by balancing neurotransmitters in the brain to improve mood and emotional regulation. Common therapeutic uses include:
- Major depressive disorder (MDD): Desvenlafaxine is primarily prescribed to treat major depressive episodes in adults, helping to alleviate symptoms such as persistent sadness, loss of interest in activities, fatigue, and sleep disturbances.
- Generalized anxiety disorder (GAD): Although it is not FDA-approved for this indication in all regions, Desvenlafaxine is sometimes used off-label for generalized anxiety disorder, where it helps reduce excessive worry, restlessness, and physical symptoms of anxiety.
- Chronic pain conditions: In some cases, Desvenlafaxine is also prescribed off-label for chronic pain conditions such as fibromyalgia and neuropathic pain, due to its dual action on serotonin and norepinephrine, which can influence pain perception.
Desvenlafaxine is contraindicated in the following situations to ensure patient safety:
- Allergy to Desvenlafaxine or other SNRIs/SSRIs: If the patient has a known hypersensitivity to Desvenlafaxine or any component of the formulation, it should not be used.
- Monoamine oxidase inhibitors (MAOIs): Desvenlafaxine should never be combined with MAOIs or used within 14 days of stopping an MAOI due to the risk of serious, life-threatening interactions such as serotonin syndrome. It is also advised not to start an MAOI until 14 days after discontinuing Desvenlafaxine.
- Severe hepatic impairment: In patients with severe liver dysfunction, the use of Desvenlafaxine is contraindicated, as the drug may not be adequately cleared by the liver, leading to increased risk of side effects.
- Uncontrolled narrow-angle glaucoma: Desvenlafaxine can increase intraocular pressure and may worsen conditions like glaucoma, particularly narrow-angle glaucoma, where the drainage of fluid in the eye is impaired.
Desvenlafaxine, like other antidepressants, may cause side effects. Most side effects are mild to moderate and may subside with continued use, but some can be severe and require immediate medical attention.
- Common side effects:
- Nausea, dry mouth, and dizziness
- Sweating and insomnia
- Fatigue, increased blood pressure (especially at higher doses)
- Decreased appetite and sexual dysfunction (such as decreased libido or erectile dysfunction)
- Severe side effects (require immediate medical attention):
- Serotonin syndrome: Symptoms may include agitation, hallucinations, rapid heartbeat, fever, and muscle rigidity.
- Hypertension: Significant increases in blood pressure may occur, especially at higher doses.
- Suicidal thoughts: Especially in young adults and adolescents, there is an increased risk of suicidal ideation or behavior. It is crucial to monitor for worsening depression or behavior changes.
- Severe allergic reactions: Signs of a serious allergic reaction include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing.
Patients should report any new or unusual symptoms to their healthcare provider, particularly if these include mood changes, suicidal thoughts, or extreme physical discomfort.
3
Desvenlafaxine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), and its primary action involves modulating the levels of two important neurotransmitters in the brain: serotonin and norepinephrine.
- Serotonin reuptake inhibition: Desvenlafaxine inhibits the reuptake of serotonin, increasing its levels in the synaptic cleft and enhancing serotonergic neurotransmission. This helps improve mood and reduce feelings of sadness or hopelessness commonly seen in depression.
- Norepinephrine reuptake inhibition: By inhibiting the reuptake of norepinephrine, Desvenlafaxine enhances its activity in the brain. Norepinephrine plays a crucial role in regulating arousal, alertness, and concentration, which helps with mood regulation and energy levels.
- Effect on both neurotransmitters: Desvenlafaxine’s action on both serotonin and norepinephrine contributes to its antidepressant effects and may provide added benefits in treating conditions such as generalized anxiety disorder (GAD) and chronic pain.
Desvenlafaxine can interact with several other medications and substances, which may alter its efficacy or increase the risk of adverse effects. Key interactions include:
- Monoamine oxidase inhibitors (MAOIs): Concomitant use of Desvenlafaxine and MAOIs can lead to serious interactions such as serotonin syndrome, characterized by symptoms like confusion, agitation, and high fever.
- Other antidepressants: When used with other serotonergic agents (e.g., SSRIs, tricyclic antidepressants, or triptans), Desvenlafaxine may increase the risk of serotonin syndrome. Caution is advised when combining these drugs.
- Anticoagulants and antiplatelet drugs: Desvenlafaxine may increase the risk of bleeding, particularly when used with anticoagulants like warfarin, nonsteroidal anti-inflammatory drugs (NSAIDs), or antiplatelet agents. Regular monitoring of bleeding risk is recommended.
- Alcohol: Alcohol may increase the sedative effects of Desvenlafaxine and can also exacerbate the side effects, such as dizziness and drowsiness. Patients should limit alcohol consumption while on this medication.
- CYP450 enzyme inducers/inhibitors: Desvenlafaxine is metabolized by the liver enzyme CYP450 2D6. Drugs that inhibit or induce this enzyme (such as fluoxetine or carbamazepine) may affect Desvenlafaxine’s effectiveness or lead to an increase in side effects.
The standard adult dosing for Desvenlafaxine is as follows:
- Starting dose: The usual starting dose is 50 mg once daily, taken in the morning, with or without food.
- Dose adjustment: Depending on the patient’s response and tolerance, the dose can be increased to a maximum of 400 mg per day. In most cases, doses above 200 mg per day are rarely required.
- Missed dose: If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next dose. It is not advisable to double up on doses to make up for a missed dose.
As always, a healthcare provider should determine the appropriate dose based on individual health needs.
Desvenlafaxine is generally not recommended for pediatric patients due to the increased risk of suicidal thoughts and behavior. However, in certain cases, it may be prescribed off-label for children or adolescents with major depressive disorder, but this should be done with careful monitoring.
- Children and adolescents: If Desvenlafaxine is prescribed for children or adolescents, the starting dose is usually 50 mg once daily, with a maximum of 200 mg daily. Close monitoring for any changes in mood or behavior is essential.
It is essential that a healthcare provider is consulted before prescribing Desvenlafaxine to any pediatric patient, as individual considerations must be taken into account.
For patients with renal impairment, Desvenlafaxine should be used with caution, and dosing adjustments may be necessary:
- Mild renal impairment (CrCl 30–50 mL/min): The usual dose may be used, but the patient should be monitored for any potential side effects.
- Moderate renal impairment (CrCl 10–29 mL/min): The dose should be reduced, typically starting at 50 mg per day, and adjusted based on patient tolerance and response.
- Severe renal impairment (CrCl < 10 mL/min): Desvenlafaxine is not recommended for use in severe renal impairment unless absolutely necessary, and dosage adjustments should be closely monitored by a healthcare provider.
Not available in a medicine form yet